Smith, M., Brunton, H., Rowling, E., Ferguson, J., Arozarena, I., Miskolczi, Z., . . . Wellbrock, C. (2016). Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy. Cancer Cell.
Chicago Style aipamenaSmith, Michael P., et al. "Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy." Cancer Cell 2016.
MLA aipamenaSmith, Michael P., et al. "Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy." Cancer Cell 2016.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.